Lack benefit methotrexate severe steroid-dependent asthma double-blind placebo-controlled study OBJECTIVE effect low-dose methotrexate asthmatic patients steroid use asthma symptom scores pulmonary function reactivity blood cellular components levels DESIGN randomized double-blind parallel placebo-controlled clinical trial follow-up patients open trial methotrexate conclusion double-blind study SETTING asthma care outpatient clinic PATIENTS February March patients severe steroid-dependent asthma study patients analysis INTERVENTIONS Patients methotrexate placebo complete absorption weekly study RESULTS Patients methotrexate steroid dose CI CI Pulmonary function methotrexate placebo groups addition reactivity symptom scores unchanged methotrexate placebo significant toxicities course blinded study patient methotrexate prednisone follow-up period Pneumocystis carinii pneumonia methotrexate year methotrexate mg significant benefit methotrexate asthma control CONCLUSION study use methotrexate treatment severe asthma 